Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar:58:101019.
doi: 10.1016/j.blre.2022.101019. Epub 2022 Oct 7.

Artificial intelligence in hematological diagnostics: Game changer or gadget?

Affiliations
Free article
Review

Artificial intelligence in hematological diagnostics: Game changer or gadget?

Wencke Walter et al. Blood Rev. 2023 Mar.
Free article

Abstract

The future of clinical diagnosis and treatment of hematologic diseases will inevitably involve the integration of artificial intelligence (AI)-based systems into routine practice to support the hematologists' decision making. Several studies have shown that AI-based models can already be used to automatically differentiate cells, reliably detect malignant cell populations, support chromosome banding analysis, and interpret clinical variants, contributing to early disease detection and prognosis. However, even the best tool can become useless if it is misapplied or the results are misinterpreted. Therefore, in order to comprehensively judge and correctly apply newly developed AI-based systems, the hematologist must have a basic understanding of the general concepts of machine learning. In this review, we provide the hematologist with a comprehensive overview of various machine learning techniques, their current implementations and approaches in different diagnostic subfields (e.g., cytogenetics, molecular genetics), and the limitations and unresolved challenges of the systems.

Keywords: Artificial intelligence; Hematological diagnostics; Machine learning; Precision medicine; Transfer learning.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest TH, CH and WK declare part ownership of MLL Munich Leukemia Laboratory. WW, CP, MM, and NN are employed by the MLL.

LinkOut - more resources